Ignite Creation Date:
2025-12-24 @ 7:06 PM
Ignite Modification Date:
2025-12-31 @ 9:06 PM
Study NCT ID:
NCT01611857
Status:
COMPLETED
Last Update Posted:
2016-11-23
First Post:
2012-06-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07
Start Date Type:
None
Primary Completion Date:
2015-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-06-01
First Submit QC Date:
None
Study First Post Date:
2012-06-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-08-09
Results First Submit QC Date:
None
Results First Post Date:
2016-11-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-03
Last Update Post Date:
2016-11-23
Last Update Post Date Type:
ESTIMATED